The legislative changes introduced by SB1139 would modify how rebates are calculated for drugs in both Medicare and commercial markets. Specifically, the bill seeks to change the base year for calculating these rebates to earlier dates, which could significantly lower the prices of certain drugs. This shift in rebate calculations is intended to reflect more current pricing trends and ensure that consumers pay fair prices reflective of actual market conditions. The bill's proponents argue that this could lead to immediate financial relief for families struggling with costly prescriptions.
Summary
SB1139, titled the 'Lower Drug Costs for Families Act', proposes amendments to Title XVIII of the Social Security Act to apply prescription drug inflation rebates not only to drugs under Medicare but also to those supplied in the commercial market. This change aims to extend the benefits of existing rebate programs to a broader range of prescription medications, potentially reducing out-of-pocket costs for consumers. By expanding these rebate applications, the bill addresses ongoing concerns regarding high drug prices and seeks to enhance access to affordable medications for families across the country.
Contention
Despite the intent to lower drug costs, there are notable points of contention surrounding this bill. Critics, including various stakeholders in the pharmaceutical industry, have raised concerns that imposing such inflation rebates on commercial drug prices could discourage innovation in drug development and lead to reduced availability of new medications. Additionally, there are worries that these changes may not sufficiently address the broader systemic issues of drug pricing and access in the healthcare system, thereby potentially failing to achieve the intended benefits for families in need.
Lower Drug Costs for Families Act This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance. Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties. The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
Lower Drug Costs for Families Act This bill applies certain Medicare prescription drug rebate requirements to prescription drugs that are available under private health insurance. Current law requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for brand-name drugs without generic equivalents under Medicare that (1) cost $100 or more per year per individual, and (2) for which prices increase faster than inflation. Manufacturers that fail to comply are subject to civil penalties. The bill applies these requirements to prescription drugs that are available in the commercial market under private health insurance. It also indexes rebate calculations to drug prices in 2016 (as opposed to 2021).
A bill for an act relating to property taxation for commercial child care centers and facilities and including effective date, applicability, and retroactive applicability provisions.(Formerly HSB 224.)
A bill for an act relating to property taxation for commercial child care centers and facilities and including effective date, applicability, and retroactive applicability provisions.(See HF 668.)
A bill for an act placing assessment limitations for property tax purposes on commercial child care facilities, and including effective date, applicability, and retroactive applicability provisions.(Formerly HSB 316.)
A bill for an act placing assessment limitations for property tax purposes on commercial child care facilities, and including effective date, applicability, and retroactive applicability provisions.(See HF 991.)
A bill for an act placing assessment limitations for property tax purposes on commercial child care facilities, and including effective date, applicability, and retroactive applicability provisions.